Arcutis Biotherapeutics has returned an impressive +200% YTD, following the successful product launch of Zoryve. See why I rate ARQT stock as a Strong Buy.

A Jersey woman has been sharing her experience of Topical Steroid Withdrawal (TSW) to raise awareness of the difficulties ...

Prior treatment use did not affect the efficacy or safety of topical ruxolitinib cream 1.5% for up to 52 weeks among patients with atopic dermatitis.

Looking down as the Emirates airline’s Boeing 777 approaches Dubai’s international airport, you can see you’re in a desert. The view is all brown sand, with a few shrubs and the occasional ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

So when Jones was prescribed a potent topical steroid to combat the condition, she was hopeful. And for a while, the medication worked. Until it didn’t. At a time when she should’ve been ...

So when Jones was prescribed a potent topical steroid to combat the condition, she was hopeful. And for a while, the medication worked. Until it didn’t. At a time when she should’ve been ...

Ruxolitinib cream initiation significantly reduces the use of other topical and systemic therapies, including corticosteroids and biologics, in atopic dermatitis patients. The findings suggest ...